SEC Comment Letter 0000000000-24-008500 to PURPLE BIOTECH LTD. (PPBT)
PURPLE BIOTECH LTD.
Date: July 26, 2024 · CIK: 0001614744 · Accession: 0000000000-24-008500
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280947
Letter
July 26, 2024 Lior Fhima Chief Financial Officer Purple Biotech Ltd. 4 Oppenheimer Street Science Park Rehovot 7670104, Israel Re:Purple Biotech Ltd. Registration Statement on Form F-1 Filed July 22, 2024 File No. 333-280947 Dear Lior Fhima: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Alla Digilova, Esq.
Show Raw Text
July 26, 2024
Lior Fhima
Chief Financial Officer
Purple Biotech Ltd.
4 Oppenheimer Street
Science Park
Rehovot 7670104, Israel
Re:Purple Biotech Ltd.
Registration Statement on Form F-1
Filed July 22, 2024
File No. 333-280947
Dear Lior Fhima:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Alla Digilova, Esq.